Your browser version may not work well with NCBI's Web applications. More information here...
1: Mol Cell Biol. 2000 Jul;20(14):5041-7.Click here to read Click here to read Links

AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor.

Font de Mora J, Brown M.

Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

Growth factor modulation of estrogen receptor (ER) activity plays an important role in both normal estrogen physiology and the pathogenesis of breast cancer. Growth factors are known to stimulate the ligand-independent activity of ER through the activation of mitogen-activated protein kinase (MAPK) and the direct phosphorylation of ER. We found that the transcriptional activity of AIB1, a ligand-dependent ER coactivator and a gene amplified preferentially in ER-positive breast cancers, is enhanced by MAPK phosphorylation. We demonstrate that AIB1 is a phosphoprotein in vivo and can be phosphorylated in vitro by MAPK. Finally, we observed that MAPK activation of AIB1 stimulates the recruitment of p300 and associated histone acetyltransferase activity. These results suggest that the ability of growth factors to modulate estrogen action may be mediated through MAPK activation of the nuclear receptor coactivator AIB1.

PMID: 10866661 [PubMed - indexed for MEDLINE]

PMCID: PMC85954

Patient Drug Information

  • Estrogen (Cenestin® , Enjuvia® , Estrace® , ...)

    Estrogen is used to treat hot flushes ('hot flashes'; sudden strong feelings of heat and sweating) in women who are experiencing menopause ('change of life', the end of monthly menstrual periods). Some brands of estrogen...

  • Source: AHFS Consumer Medication Information